Milena A Ozimek

Milena A Ozimek,

Administrative Support Assistant

Department: Pharmaceutics
Business Phone: (407) 313-7050
Business Email: mozimek@ufl.edu

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0002-4998-1167

Publications

2023
PK / PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris
CPT: Pharmacometrics & Systems Pharmacology. [DOI] 10.1002/psp4.12949.
2023
Barriers to global pharmacometrics: educational challenges and opportunities across the globe
CPT: Pharmacometrics & Systems Pharmacology. [DOI] 10.1002/psp4.12940.
2023
Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies
CPT: Pharmacometrics & Systems Pharmacology. [DOI] 10.1002/psp4.12973.
2023
Leveraging Physiologically Based Modelling to Provide Insights on the Absorption of Paliperidone Extended-Release Formulation under Fed and Fasting Conditions
Pharmaceutics. 15(2) [DOI] 10.3390/pharmaceutics15020629. [PMID] 36839950.
2023
Model-Based Analysis of In Vivo Release Data of Levonorgestrel Implants: Projecting Long-Term Systemic Exposure
Pharmaceutics. 15(5) [DOI] 10.3390/pharmaceutics15051393.
2023
Requirements, expectations, challenges and opportunities associated with training the next generation of pharmacometricians
CPT: Pharmacometrics & Systems Pharmacology. [DOI] 10.1002/psp4.12970.
2023
The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies
CPT: Pharmacometrics & Systems Pharmacology. [DOI] 10.1002/psp4.12927. [PMID] 36752286.
2022
Application of exposure bracketing to streamline the development of contraceptive products
Contraception: X. 4 [DOI] 10.1016/j.conx.2022.100072. [PMID] 35243326.
2022
Development of a model‐based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy
CPT: Pharmacometrics & Systems Pharmacology. 11(3):318-332 [DOI] 10.1002/psp4.12753. [PMID] 34877803.
2022
Development of a Translational Exposure‐Bracketing Approach to Streamline the Development of Hormonal Contraceptive Drug Products
Clinical Pharmacology & Therapeutics. 112(4):909-916 [DOI] 10.1002/cpt.2690.
2022
Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid
International Journal of Antimicrobial Agents. 59(2) [DOI] 10.1016/j.ijantimicag.2021.106509.
2020
Pharmacokinetics of tedizolid, sutezolid, and sutezolid-M1 in non-human primates
European Journal of Pharmaceutical Sciences. 151 [DOI] 10.1016/j.ejps.2020.105421.
2020
Population Pharmacokinetic Modeling of Acetaminophen Protein Adducts in Adults and Children
The Journal of Clinical Pharmacology. 60(5):595-604 [DOI] 10.1002/jcph.1555. [PMID] 31802503.
2019
Acetaminophen Protein Adducts in Hospitalized Children Receiving Multiple Doses of Acetaminophen
The Journal of Clinical Pharmacology. 59(10):1291-1299 [DOI] 10.1002/jcph.1442. [PMID] 31099052.

Contact Details

Phones:
Business:
(407) 313-7050
Emails:
Business:
mozimek@ufl.edu
Addresses:
Business Mailing:
6550 SANGER RD OFC 465
ORLANDO FL 32827
Business Street:
6550 SANGER RD
ORLANDO FL 32827